| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/30/2005 | CN1703203A Organoleptically acceptable intraorally disintegrating compositions |
| 11/30/2005 | CN1703199A Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug |
| 11/30/2005 | CN1703198A Depot formulations of arylheterocyclic active agents in the form of a suspension |
| 11/30/2005 | CN1703197A Injectable depot compositions and uses thereof |
| 11/30/2005 | CN1703186A Biliquid foam entrapment |
| 11/30/2005 | CN1701792A Preparation for external use on skin |
| 11/30/2005 | CN1229390C Peptides that lower blood glucose levels |
| 11/30/2005 | CN1229388C N-terminal modified protein compositions and methods therefor |
| 11/30/2005 | CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof |
| 11/30/2005 | CN1229138C Method for accelerating rate of mucociliary clearance |
| 11/30/2005 | CN1229136C Laerimal gland specific emulsions for topical application to ocular tissue |
| 11/30/2005 | CN1229112C Rapid onset preparation |
| 11/30/2005 | CN1229111C Sustained release preparations |
| 11/30/2005 | CN1229110C Ophthalmic compositions containing galactomannan polymers and borate |
| 11/29/2005 | US6969593 Method for the selective survival or selective growth of a target cell by the use of a conjugate, its use in therapeutics and/or diagnostics and the preparation of said conjugate |
| 11/29/2005 | US6969590 Use of a polypeptide for treatment of pruritus in animals |
| 11/29/2005 | US6969528 novel phosphorus-containing dendrimers which are functionalized at the level of the inner layers and which comprise protonated tertiary amines as ends, have particularly advantageous properties as vectors for transferring nucleic acids |
| 11/29/2005 | US6969524 Interferon complex and medicinal use thereof |
| 11/29/2005 | US6969515 Comprises proteolytic enzymes; free of plasminogen activator |
| 11/29/2005 | US6969400 bioadhesives, for tissue augmentation, in the prevention of surgical adhesions, and for coating surfaces of synthetic implants, as drug delivery matrices and for ophthalmic applications |
| 11/29/2005 | US6968840 Coupling a nebule to an interface of the aerosol generator; reading an identification marker on the nebule; operating the aerosol generator by vibrating the vibratory element according to an operation program based on the information |
| 11/29/2005 | CA2326660C Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases |
| 11/29/2005 | CA2251430C Omeprazole formulation |
| 11/29/2005 | CA2235346C Composition for transdermal delivery |
| 11/29/2005 | CA2223960C Reconstituted collagen fiber segment compositions and methods of preparation thereof |
| 11/28/2005 | CA2508096A1 Percutaneous absorption accelerator |
| 11/28/2005 | CA2508093A1 Preparation for external use on skin |
| 11/24/2005 | WO2005111224A2 Water-soluble coenzyme q10 in inclusion complex with beta-cyclodextrin, process of preparing, and use thereof |
| 11/24/2005 | WO2005111198A1 Cancerous disease modifying antibodies |
| 11/24/2005 | WO2005111196A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 11/24/2005 | WO2005110491A2 Inducible dimerization of growth factor receptors for treating cancer |
| 11/24/2005 | WO2005110489A2 Nucleic acid aptamers conjugated to high molecular weight steric groups |
| 11/24/2005 | WO2005110488A1 Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same |
| 11/24/2005 | WO2005110487A2 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
| 11/24/2005 | WO2005110486A2 7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists |
| 11/24/2005 | WO2005110485A1 Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 11/24/2005 | WO2005110484A2 Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
| 11/24/2005 | WO2005110483A2 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 11/24/2005 | WO2005110482A1 Percutaneous pharmaceutical preparation for external use containing nonsteroidal antiinflammatory analgesic |
| 11/24/2005 | WO2005110473A2 Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases |
| 11/24/2005 | WO2005110466A1 Hydrogel interferon formulations |
| 11/24/2005 | WO2005110438A2 Methods and products related to the intracellular delivery of polysaccharides |
| 11/24/2005 | WO2005110436A2 Macromolecule-containing sustained release intraocular implants and related methods |
| 11/24/2005 | WO2005110434A1 Topical treatment and prevention of human papilloma virus (hpv) infection |
| 11/24/2005 | WO2005110431A1 Herbal product containing glucosamine |
| 11/24/2005 | WO2005110430A1 Method of use of carboxylated polysaccharides topically on the eyeball |
| 11/24/2005 | WO2005110427A1 Stable oral pharmaceutical preparation comprising fosfomycin, which is intended for diabetic patients |
| 11/24/2005 | WO2005110420A1 Controlled-release formulations containing vardenafil |
| 11/24/2005 | WO2005110419A1 Controlled-release formulations containing vardenafil |
| 11/24/2005 | WO2005110418A2 Transdermal administration of phycotoxins |
| 11/24/2005 | WO2005110385A1 Composition for prolonging the residence time of drugs in the gut and use thereof |
| 11/24/2005 | WO2005110377A1 Gel composition comprising charged polymers |
| 11/24/2005 | WO2005110374A1 Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| 11/24/2005 | WO2005110372A1 Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water |
| 11/24/2005 | WO2005110363A2 Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles |
| 11/24/2005 | WO2005110361A2 Nucleotide-cochleate compositions and methods of use |
| 11/24/2005 | WO2005110360A2 Compositions for injection |
| 11/24/2005 | WO2005110277A2 Carboxylated polysaccharides and method of preparation and use |
| 11/24/2005 | WO2005110090A1 Hydrogen peroxide-based skin disinfectant |
| 11/24/2005 | WO2005110046A2 Method of enhancing uptake of keratinocyte growth factor |
| 11/24/2005 | WO2005110002A2 Anti-inflammatory and anticeptic suppository exhibiting a regeneration effect |
| 11/24/2005 | WO2005082332A3 Dissolvable film comprising an active ingredient and method of manufacture |
| 11/24/2005 | WO2005076829A3 Stable loratadine spill resistant formulation |
| 11/24/2005 | WO2005059508A3 Cellular probes |
| 11/24/2005 | WO2005058958A3 Novel glp-1 analogues linked to albumin-like agents |
| 11/24/2005 | WO2005046641A3 Compositions and methods for treating a posterior segment of an eye |
| 11/24/2005 | WO2005028539A3 Multi-arm polymer prodrugs |
| 11/24/2005 | WO2005011647A2 Pharmaceutical composition |
| 11/24/2005 | WO2004110420A8 Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen |
| 11/24/2005 | WO2004104021A3 Controlled release of active agents utilizing repeat sequence protein polymers |
| 11/24/2005 | WO2004060303A3 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 11/24/2005 | US20050261750 Method and apparatus for acne treatment |
| 11/24/2005 | US20050261584 Devices and methodologies useful in body aesthetics |
| 11/24/2005 | US20050261472 Binding moieties for fibrin |
| 11/24/2005 | US20050261335 Carvedilol formulations |
| 11/24/2005 | US20050261281 Pharmaceutical compounds |
| 11/24/2005 | US20050261280 Stabilized antihistamine syrup |
| 11/24/2005 | US20050261253 Pharmacokinetics; bioavailability |
| 11/24/2005 | US20050261232 Non-natural ribonuclease conjugates as cytotoxic agents |
| 11/24/2005 | US20050261214 Complexes for transferring substances of interest into a cell |
| 11/24/2005 | US20050261189 Methods of promoting cardiac cell proliferation |
| 11/24/2005 | US20050261173 Antifungal parenteral products |
| 11/24/2005 | US20050261170 Folate conjugates and complexes |
| 11/24/2005 | US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III |
| 11/24/2005 | US20050261163 Pharmaceutical products, preparation and uses thereof |
| 11/24/2005 | US20050260651 Enhanced biologically active conjugates |
| 11/24/2005 | US20050260597 Transfection reagents |
| 11/24/2005 | US20050260544 Novel device |
| 11/24/2005 | US20050260276 Methods and articles for the delivery of therapeutic agents |
| 11/24/2005 | US20050260271 Composition comprising layered host material with intercalated functional-active organic compound |
| 11/24/2005 | US20050260261 Neutral-cationic lipid for nucleic acid and drug delivery |
| 11/24/2005 | US20050260259 Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 11/24/2005 | US20050260256 Methods and apparatus for extrusion of vesicles at high pressure |
| 11/24/2005 | US20050260255 Adhesive patch |
| 11/24/2005 | US20050260253 Transmucosal gel formulations |
| 11/24/2005 | US20050260250 Medicinal products incorporating bound organosulfur groups |
| 11/24/2005 | US20050260237 Delivery Agents for enhancing mucosal absorption of therapeutic agents |
| 11/24/2005 | US20050260228 Vaccines absorbable by the transmucosal way |
| 11/24/2005 | US20050260215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 11/24/2005 | US20050260214 Composition and method for introduction of RNA interference sequences into targeted cells and tissues |